Brief: India's Suven Life Sciences Secures Product Patents In Eurasia, Norway
06/12/2017 04:53
Dec 6 (Reuters) - Suven Life Sciences Ltd SUVP.NS :
* SAYS SECURES PRODUCT PATENTS IN EURASIA AND NORWAY
* PATENTS CORRESPONDS TO NEW CHEMICAL ENTITIES (NCES) FOR
TREATMENT OF DISORDERS ASSOCIATED WITH NEURODEGENERATIVE
DISEASES
Source text - http://bit.ly/2AUMl7N
Further company coverage: SUVP.NS
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Suven Life Sciences
See all newsBrief: Suven Life Sciences Completes Phase-1 Study Of SUVN-I6107, Advances To Phase-2
Brief: Suven Life Sciences Reports Positive DSMB Safety Review For Phase-3 Masupirdine Study
Brief: Suven Life Sciences Records 100% Patient Enrolment Milestone In Phase-2B Clinical Trial Of Ropanicant
Brief: Suven Life Sciences Says First Patient Randomized In Phase-2B Clinical Trial Of Ropanicant
Brief: Suven Life Sciences March-Quarter Consol Net Loss 439.4 Million Rupees